James G. Marken serves as Executive at BIOSANTE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, James G. Marken has executed 64 insider transactions totaling $5.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 5, 2018 involved exercising options for 3,208 shares valued at $105.9K.
James G. Marken currently holds 117,829 shares of BIOSANTE PHARMACEUTICALS INC (BPAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James G. Marken has been a net seller of BPAX stock. They have purchased $0 and sold $5.1M worth of shares.
James G. Marken's most recent insider trade was on Mar 5, 2018, when they sold 3,208 shares at $33.00 per share.
Get notified when new Form 4 filings are submitted
| 278 |
| $47.01 |
| Discretionary |
| Mar 31, 2017 | ANIP | $0 | Award | 3,625 | $N/A | Discretionary |
| Apr 7, 2016 | ANIP | $0 | Award | 1,875 | $N/A | Discretionary |
| Dec 18, 2015 | ANIP | $151.4K | Sale | 3,500 | $43.26 | Discretionary |
| Jul 17, 2015 | ANIP | $47.0K | Option Exercise | 7,395 | $6.36 | Discretionary |
| May 13, 2015 | ANIP | $53.6K | Option Exercise | 1,625 | $33.00 | Discretionary |
| May 13, 2015 | ANIP | $47.0K | Option Exercise | 7,395 | $6.36 | Discretionary |
| Apr 16, 2015 | ANIP | $0 | Award | 1,500 | $N/A | Discretionary |
| Mar 19, 2015 | ANIP | $997.5K | Sale | 15,000 | $66.50 | Discretionary |
| Jun 18, 2014 | ANIP | $171.4K | Sale | 5,000 | $34.28 | Discretionary |
| May 22, 2014 | ANIP | $0 | Award | 3,300 | $N/A | Discretionary |
| Jun 19, 2013 | BPAX | $0 | Award | 435,241 | $N/A | Discretionary |
| Jun 19, 2013 | BPAX | $0 | Payment | 145,629 | $N/A | Discretionary |